Tamar RapaportDagim - Amdocs President
| DOX Stock | USD 85.67 0.47 0.55% |
President
Ms. Tamar RapaportDagim serves as Senior Vice President and Chief Financial Officer of Amdocs Management Limited, subsidiary of Amdocs Limited., since November 2007 since 2007.
| Age | 53 |
| Tenure | 17 years |
| Address | 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141 |
| Phone | 314 212 7000 |
| Web | https://www.amdocs.com |
Amdocs Management Efficiency
The company has Return on Asset of 0.0738 % which means that on every $100 spent on assets, it made $0.0738 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1405 %, implying that it generated $0.1405 on every 100 dollars invested. Amdocs' management efficiency ratios could be used to measure how well Amdocs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.10 in 2024. Return On Capital Employed is likely to drop to 0.14 in 2024. At this time, Amdocs' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 307 M in 2024, whereas Total Assets are likely to drop slightly above 4.5 B in 2024.Similar Executives
| Found 8 records | PRESIDENT Age | ||
| Damian Cecchi | Global Blue Group | 51 | |
| Sai Ho | BlackBerry | 67 | |
| Bojun Song | Datasea | N/A | |
| John Ganley | Veritone | 76 | |
| Loic Jenouvrier | Global Blue Group | 52 | |
| Nita WhiteIvy | BlackBerry | 71 | |
| Ryan Steelberg | Veritone | 50 | |
| Thomas Eacobacci | BlackBerry | 49 | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0738 |
Amdocs Leadership Team
Elected by the shareholders, the Amdocs' board of directors comprises two types of representatives: Amdocs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amdocs. The board's role is to monitor Amdocs' management team and ensure that shareholders' interests are well served. Amdocs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amdocs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joshua Sheffer, CEO President | ||
| Darcy Antonellis, Head Media | ||
| Oren Marmur, Head Network | ||
| Gary Miles, Chief Officer | ||
| Matthew Smith, Corporate Secretary | ||
| Avishai Sharlin, GM President | ||
| Mustafa Oyumi, Head Strategy | ||
| Idit Aronsohn, Inclusion Responsibility | ||
| Tamar RapaportDagim, Senior Vice President and CFO of Amdocs Management Limited | ||
| Anthony Goonetilleke, Group Strategy | ||
| Rajat Raheja, Division President Amdocs Development Center India Pvt. Ltd |
Amdocs Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amdocs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0738 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 10.13 B | ||||
| Shares Outstanding | 115 M | ||||
| Shares Owned By Institutions | 98.41 % | ||||
| Number Of Shares Shorted | 2.86 M | ||||
| Price To Earning | 19.03 X | ||||
| Price To Book | 2.85 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Amdocs Stock Analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.